Bamboo extract reduces interleukin 6 (IL-6) overproduction under lipotoxic conditions through inhibiting the activation of NF-κB and AP-1 pathways

Cytokine

Volumn 55, Issue 1, 2011, Pages 18-23

  Higa, Jason K ^a   Panee, Jun ^a  

^a UNIVERSITY OF HAWAII   (United States)

Author keywords

AP 1; Bamboo extract; IL 6; Lipotoxicity; NF B

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; MESSENGER RNA; PALMITIC ACID; PHYLLOSTACHYS EDULIS EXTRACT; PLANT EXTRACT; PROTEIN C FOS; PROTEIN P50; SYNAPTOTAGMIN I; TRANSCRIPTION FACTOR AP 1; UNCLASSIFIED DRUG;

ADIPOSE TISSUE CELL; ANIMAL CELL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL DIFFERENTIATION; CELL LEVEL; CELL METABOLISM; CELL NUCLEUS; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOSOL; EXTRACELLULAR SPACE; GENE ACTIVATION; GENE EXPRESSION REGULATION; GENE TRANSLOCATION; LIPOTOXICITY; LIVER CELL; MEDICINAL PLANT; MOUSE; MYOBLAST; MYOTUBE; NONHUMAN; PHYLLOSTACHYS EDULIS; PHYTOCHEMISTRY; PLANT LEAF; PRIORITY JOURNAL; PROTEIN SYNTHESIS REGULATION; TRANSCRIPTION REGULATION; UPREGULATION;

3T3-L1 CELLS; ADIPOCYTES; ANIMALS; APOPTOSIS; BAMBUSA; CELL NUCLEUS; CULTURE MEDIA; GENE EXPRESSION REGULATION; INTERLEUKIN-6; MICE; NF-KAPPA B; NF-KAPPA B P50 SUBUNIT; PALMITIC ACID; PHYTOTHERAPY; PLANT EXTRACTS; PROTEIN TRANSPORT; PROTO-ONCOGENE PROTEINS C-FOS; RNA, MESSENGER; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTOR AP-1; TRANSCRIPTION FACTOR RELA; TRANSCRIPTION, GENETIC;

MURINAE; PHYLLOSTACHYS PUBESCENS;

EID: 79956364732     PISSN: 10434666     EISSN: 10960023     Source Type: Journal    
DOI: 10.1016/j.cyto.2011.02.019     Document Type: Article

References (28)

1. Abeywardena M.Y., Leifert W.R., Warnes K.E., Varghese J.N., Head R.J. Cardiovascular biology of interleukin-6. Curr Pharm Des 2009, 15:1809-1821.
2. Yudkin J.S., Kumari M., Humphries S.E., Mohamed-Ali V. Inflammation, obesity, stress and coronary heart disease: is interleukin-6 the link?. Atherosclerosis 2000, 148:209-214.
3. Mohamed-Ali V., Goodrick S., Rawesh A., Katz D.R., Miles J.M., Yudkin J.S., et al. Subcutaneous adipose tissue releases interleukin-6, but not tumor necrosis factor-alpha, in vivo. J Clin Endocrinol Metab 1997, 82:4196-4200.
4. Fried S.K., Bunkin D.A., Greenberg A.S. Omental and subcutaneous adipose tissues of obese subjects release interleukin-6: depot difference and regulation by glucocorticoid. J Clin Endocrinol Metab 1998, 83:847-850.
5. Ostrowski K., Rohde T., Zacho M., Asp S., Pedersen B.K. Evidence that interleukin-6 is produced in human skeletal muscle during prolonged running. J Physiol 1998, 508:949-953.
6. Danesh J., Whincup P., Walker M., Lennon L., Thomson A., Appleby P., et al. Low grade inflammation and coronary heart disease: prospective study and updated meta-analyses. BMJ 2000, 321:199-204.
7. Fernández-Real J.M. Genetic predispositions to low-grade inflammation and type 2 diabetes. Diabetes Technol Ther 2006, 8:55-66.
8. Yudkin J.S., Stehouwer C.D., Emeis J.J., Coppack S.W. C-reactive protein in healthy subjects: associations with obesity, insulin resistance, and endothelial dysfunction: a potential role for cytokines originating from adipose tissue?. Arterioscler Thromb Vasc Biol 1999, 19:972-978.
9. Fernandez-Real J.M., Vayreda M., Richart C., Gutierrez C., Broch M., Vendrell J., et al. Circulating interleukin 6 levels, blood pressure, and insulin sensitivity in apparently healthy men and women. J Clin Endocrinol Metab 2001, 86:1154-1159.
10. De Lorenzo A., Del Gobbo V., Premrov M.G., Bigioni M., Galvano F., Di Renzo L. Normal-weight obese syndrome: early inflammation?. Am J Clin Nutr 2007, 85:40-45.
11. Di Renzo L., Bertoli A., Bigioni M., Del Gobbo V., Premrov M.G., Calabrese V., et al. Body composition and -174G/C interleukin-6 promoter gene polymorphism: association with progression of insulin resistance in normal weight obese syndrome. Curr Pharm Des 2008, 14:2699-2706.
12. Romano M., Sironi M., Toniatti C., Polentarutti N., Fruscella P., Ghezzi P., et al. Role of IL-6 and its soluble receptor in induction of chemokines and leukocyte recruitment. Immunity 1997, 6:315-325.
13. Harris T.B., Ferrucci L., Tracy R.P., Corti M.C., Wacholder S., Ettinger W.H., et al. Associations of elevated interleukin-6 and C-reactive protein levels with mortality in the elderly. Am J Med 1999, 106:506-512.
14. van Herpen NA, Schrauwen-Hinderling VB. Lipid accumulation in non-adipose tissue and lipotoxicity. Physiol Behav 2007; Epub ahead of print.
15. Shi H., Kokoeva M.V., Inouye K., Tzameli I., Yin H., Flier J.S. TLR4 links innate immunity and fatty acid-induced insulin resistance. J Clin Invest 2006, 116:3015-3025.
16. Song M.J., Kim K.H., Yoon J.M., Kim J.B. Activation of Toll-like receptor 4 is associated with insulin resistance in adipocytes. Biochem Biophys Res Commun 2006, 346:739-745.
17. Ohashi K., Kanazawa A., Tsukada S., Maeda S. PKCepsilon induces interleukin-6 expression through the MAPK pathway in 3T3-L1 adipocytes. Biochem Biophys Res Commun 2005, 327:707-712.
18. Ntambi J.M., Kim Y.C. Adipocyte differentiation and gene expression. J Nutr 2000, 130:3122S-3126S.
19. Harkins J.M., Moustaid-Moussa N., Chung Y.J., Penner K.M., Pestka J.J., North C.M., et al. Expression of interleukin-6 is greater in preadipocytes than in adipocytes of 3T3-L1 cells and C57BL/6J and ob/ob mice. J Nutr 2004, 134:2673-2677.
20. Panee J., Liu W., Lin Y., Gilman C., Berry M.J. A novel function of bamboo extract in relieving lipotoxicity. Phytother Res 2008, 22:675-680.
21. Ye Z., Huang Q., Ni H.X., Wang D. Cortex lycii radicis extracts improve insulin resistance and lipid metabolism in obese-diabetic rats. Phytother Res 2008, 22:1665-1670.
22. DeFuria J., Bennett G., Strissel K.J., Perfield J.W., Milbury P.E., Greenberg A.S., et al. Dietary blueberry attenuates whole-body insulin resistance in high fat-fed mice by reducing adipocyte death and its inflammatory sequelae. J Nutr 2009, 139:1510-1516.
23. Chacón M.R., Ceperuelo-Mallafré V., Maymó-Masip E., Mateo-Sanz J.M., Arola L., Guitiérrez C., et al. Grape-seed procyanidins modulate inflammation on human differentiated adipocytes in vitro. Cytokine 2009, 47:137-142.
24. Qin B., Dawson H., Polansky M.M., Anderson R.A. Cinnamon extract attenuates TNF-alpha-induced intestinal lipoprotein ApoB48 overproduction by regulating inflammatory, insulin, and lipoprotein pathways in enterocytes. Horm Metab Res 2009, 41:516-522.
25. Keophiphath M., Priem F., Jacquemond-Collet I., Clément K., Lacasa D. 1,2-Vinyldithiin from garlic inhibits differentiation and inflammation of human preadipocytes. J Nutr 2009, 139:2055-2060.
26. Seymour E.M., Lewis S.K., Urcuyo-Llanes D.E., Tanone I.I., Kirakosyan A., Kaufman P.B., et al. Regular tart cherry intake alters abdominal adiposity, adipose gene transcription, and inflammation in obesity-prone rats fed a high fat diet. J Med Food 2009, 12:935-942.
27. Markovits N., Ben Amotz A., Levy Y. The effect of tomato-derived lycopene on low carotenoids and enhanced systemic inflammation and oxidation in severe obesity. Isr Med Assoc J 2009, 11:598-601.
28. Fischer-Posovszky P, Kukulus V, Tews D, Unterkircher T, Debatin KM, Fulda S et al. Resveratrol regulates human adipocyte number and function in a Sirt1-dependent manner. The American journal of clinical nutrition 2010; Epub ahead of print.